Search Results - "Lamberti, S. V."

Hyperhomocysteinemia in L-dopa treated patients with Parkinson's disease: potential implications in cognitive dysfunction and dementia? by Zoccolella, S, Lamberti, S V, Iliceto, G, Santamato, A, Lamberti, P, Logroscino, G

“…Hyperhomocysteinemia has been associated with cognitive dysfunction and dementia. The incidence of dementia in Parkinson's Disease (PD) patients is higher than…”
Get more information

Hyperhomocysteinemia in l-dopa treated Parkinson's disease patients: effect of cobalamin and folate administration by Lamberti, P., Zoccolella, S., Armenise, E., Lamberti, S. V., Fraddosio, A., de Mari, M., Iliceto, G., Livrea, P.

“…Homocysteine (Hcy) is a risk factor for vascular diseases, cognitive impairment and dementia. l‐dopa treatment may represent an acquired cause of…”
Get full text

Plasma homocysteine levels in Parkinson's disease: role of antiparkinsonian medications by Zoccolella, S., Lamberti, P., Armenise, E., Mari, M. de, Lamberti, S.V., Mastronardi, R., Fraddosio, A., Iliceto, G., Livrea, P.

“…Elevated plasma homocysteine (Hcy) concentrations have been reported in l-dopa treated Parkinson's disease (PD) patients, suggesting that l-dopa treatment is…”
Get full text

Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctions by Zoccolella, Stefano, Lamberti, Paolo, Iliceto, Giovanni, Diroma, Cosimo, Armenise, Elio, Defazio, Giovanni, Lamberti, Simona V, Fraddosio, Angela, de Mari, Michele, Livrea, Paolo

“…Elevated plasma homocysteine (Hcy) concentrations are associated with Alzheimer's disease and vascular dementia. Several recent reports have indicated that…”
Get more information

Subantral graft: clinical application of the biological principles osseoinduction in the treatment of posterior maxillary atrophy by Lamberti, V S

“…Severe resorption in the posterior maxilla following the loss of natural teeth is frequently associated with severe pneumatization of the maxillary sinus. This…”
Get more information